| [1] |
Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016 [J]. CA Cancer J Clin, 2016, 66(4): 271-289.
|
| [2] |
Bowles EJ, Wellman R, Feigelson HS, et al. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study [J]. J Natl Cancer Inst, 2012, 104(17): 1293-1305.
|
| [3] |
Carvalho FS, Burgeiro A, Garcia R, et al. Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy [J]. Med Res Rev, 2014, 34(1): 106-135.
|
| [4] |
Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management [J]. J Am Coll Cardiol, 2009, 53(24): 2231-2247.
|
| [5] |
Lancellotti P, Nkomo VT, Badano LP, et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography [J]. J Am Soc Echocardiogr, 2013, 26(11): 1305.
|
| [6] |
Aapro M, Bernard-Marty C, Brain EG, et al. Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper [J]. Ann Oncol, 2011, 22(2): 257-267.
|
| [7] |
Zambetti M, Moliterni A, Materazzo C, et al. Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation [J]. J Clin Oncol, 2001, 19(1): 37-43.
|
| [8] |
Tassan-mangina S, Codorean D, Metivier M, et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: Early and late alterations of left ventricular function during a prospective study [J]. Eur J Echocardiogr, 2006, 7(2): 141-146.
|
| [9] |
Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials [J]. Cancer, 2003, 97(11): 2869-2879.
|
| [10] |
Seidman A, Hudis C, Pierri MK, et al. Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience [J]. J Clin Oncol, 2002, 20(5): 1215-1221.
|
| [11] |
Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging [J]. Eur Heart J Cardiovasc Imaging, 2014, 15(10): 1063-1093.
|
| [12] |
Santoro C, Arpino G, Esposito R, et al. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility [J]. Eur Heart J Cardiovasc Imaging, 2017, 18(8): 930-936.
|
| [13] |
Khouri MG, Hornsby WE, Risum N, et al. Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy [J]. Breast Cancer Res Treat, 2014, 143(3): 531-539.
|
| [14] |
Boyd A, Stoodley P, Richards D, et al. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study [J]. PLoS One, 2017, 12(4): e0175544.
|
| [15] |
Florescu M, Magda LS, Enescu OA, et al. Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer [J]. J Am Soc Echocardiogr, 2014, 27(1): 83-92.
|
| [16] |
Fei HW, Ali MT, Tan TC, et al. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction [J]. Echocardiography, 2016, 33(4): 519-526.
|
| [17] |
Tan TC, Bouras S, Sawaya H, et al. Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab [J]. J Am Soc Echocardiogr, 2015, 28(5): 509-514.
|
| [18] |
Narayan HK, Finkelman B, French B, et al. Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations With Ejection Fraction Decline, Recovery, and Heart Failure Symptoms Over 3 Years of Follow-Up [J]. Circulation, 2017, 135(15): 1397-1412.
|
| [19] |
Venneri L, Zoppellaro G, Khattar RS. Cardio-oncology: the role of advanced echocardiography in cancer patients [J]. Expert Rev Cardiovasc Ther, 2018, 16(4): 249-258.
|
| [20] |
Mor-Avi V, Lang RM, Badano LP, et al. Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications [J]. J Am Soc Echocardiogr, 2011, 24(3): 277-313.
|
| [21] |
Stanton T, Leano R, Marwick TH. Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring [J]. Circ Cardiovasc Imaging, 2009, 2(5): 356-364.
|
| [22] |
Lorenzini C, Lamberti C, Aquilina M, et al. Reliability of Left Ventricular Ejection Fraction from Three-Dimensional Echocardiography for Cardiotoxicity Onset Detection in Patients with Breast Cancer [J]. J Am Soc Echocardiogr, 2017, 30(11): 1103-1110.
|
| [23] |
Thavendiranathan P, Poulin F, Lim KD, et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review [J]. J Am Coll Cardiol, 2014, 63(25 Pt A): 2751-2768.
|
| [24] |
Sawaya H, Sebag IA, Plana JC, et al. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab [J]. Circ Cardiovasc Imaging, 2012, 5(5): 596-603.
|
| [25] |
Negishi K, Negishi T, Hare JL, et al. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity [J]. J Am Soc Echocardiogr, 2013, 26(5): 493-498.
|
| [26] |
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2016, 37(36): 2768-2801.
|
| [27] |
Gripp EA, Oliveira GE, Feijó LA, et al. Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment [J]. Arq Bras Cardiol, 2018, 110(2): 140-150.
|
| [28] |
Lange SA, Jung J, Jaeck A, et al. Subclinical Myocardial Impairment Occurred in Septal and Anterior LV Wall Segments After Anthracycline-Embedded Chemotherapy and did not Worsen During Adjuvant Trastuzumab Treatment in Breast Cancer Patients [J]. Cardiovasc Toxicol, 2016, 16(2): 193-206.
|
| [29] |
Stoodley PW, Richards DA, Boyd A, et al. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months [J]. Eur J Cancer, 2013, 49(16): 3396-3403.
|
| [30] |
Toufan M, Pourafkari L, Ghahremani Nasab L, et al. Two-dimensional strain echocardiography for detection of cardiotoxicity in breast cancer patients undergoing chemotherapy [J]. J Cardiovasc Thorac Res, 2017, 9(1): 29-34.
|
| [31] |
韩勇，董云，刘怡, 等. 左心室整体心肌应变分析乳腺癌术后蒽环类化疗药物心脏毒性 [J]. 中华超声影像学杂志, 2014, 23(2): 104-108.
|
| [32] |
陈婕，陈剑琼，王玲, 等. 三维斑点追踪技术评价蒽环类药物对乳腺癌患者左室心肌功能损害 [J]. 中华超声影像学杂志, 2015(9): 763-767.
|
| [33] |
唐水娟，李俊玲，刘稳刚, 等. 三维应变联合血清MMP-9/TIMP-1评价蒽环类药物化疗后左室收缩功能的改变 [J]. 中国超声医学杂志, 2014, 30(4): 320-324.
|
| [34] |
Walker J, Bhullar N, Fallah-Rad N, et al. Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging [J]. J Clin Oncol, 2010, 28(21): 3429-3436.
|
| [35] |
Thavendiranathan P, Grant AD, Negishi T, et al. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy [J]. J Am Coll Cardiol, 2013, 61(1): 77-84.
|
| [36] |
Ho E, Brown A, Barrett P, et al. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study [J]. Heart, 2010, 96(9): 701-707.
|
| [37] |
Luo R, Cui H, Huang D, et al. Early assessment of the left ventricular function by epirubicin-induced cardiotoxicity in postoperative breast cancer patients [J]. Echocardiography, 2017, 34(11): 1601-1609.
|
| [38] |
de Azambuja E, Ameye L, Diaz M, et al. Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy [J]. Eur J Cancer, 2015, 51(17): 2517-2524.
|
| [39] |
Tsai HR, Gjesdal O, Wethal T, et al. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin′s lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy [J]. Am J Cardiol, 2011, 107(3): 472-477.
|
| [40] |
Zhang KW, Finkelman BS, Gulati G, et al. Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction [J]. JACC Cardiovasc Imaging, 2018, 11(8): 1059-1068.
|
| [41] |
赵宇心，印国兵，任建丽, 等. 多种超声心动图技术评估乳腺癌患者放化疗相关心脏毒性的临床研究 [J]. 中国超声医学杂志, 2018, 34(4): 315-318.
|
| [42] |
Narayan HK, Finkelman B, French B, et al. Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations With Ejection Fraction Decline, Recovery, and Heart Failure Symptoms Over 3 Years of Follow-Up [J]. Circulation, 2017, 135(15): 1397-1412.
|
| [43] |
Tanindi A, Demirci U, Tacoy G, et al. Assessment of right ventricular functions during cancer chemotherapy [J]. Eur JEchocardiogr, 2011, 12(11): 834-840.
|
| [44] |
Boczar KE, Aseyev O, Sulpher J, et al. Right heart function deteriorates in breast cancer patients undergoing anthracycline-based chemotherapy [J]. Echo Res Pract, 2016, 3(3): 79-84.
|
| [45] |
Chang WT, Shih JY, Feng YH, et al. The Early Predictive Value of Right Ventricular Strain in Epirubicin-Induced Cardiotoxicity in Patients with Breast Cancer [J]. Acta Cardiol Sin, 2016, 5(32): 550-559.
|
| [46] |
王燕，张平洋，刘琨, 等. 三维斑点追踪成像技术评价乳腺癌患者接受吡柔比星化疗后右心室心肌力学特性改变 [J]. 南方医科大学学报, 2018, 38(9): 1032-1038.
|